Richard A. Paulson, President and CEO at Karyopharm Therapeutics Inc. (KPTI), sold 3,576 shares at $1.13 ($4K) on 2024-05-06, disclosed to the SEC on 2024-05-07.
Seasonal sale ($4k) by President and CEO — this insider has traded KPTI in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| KPTI | SELL | 2025-09-16 | $8K | — | Filing → |
| KPTI | SELL | 2025-05-07 | $2K | — | Filing → |
| KPTI | SELL | 2025-04-07 | $916 | — | Filing → |